Medicenna Therapeutics Corp. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2021-12-22: Form 6-K; Period of report 2021-12-22; Description FORM 6-K; Document f6k_122221.htm.
- 2021-12-17: Form 6-K; Period of report 2021-12-17; Description FORM 6-K; Document f6k_121721.htm.
- 2021-11-18: Form 6-K; Period of report 2021-11-18; Description FORM 6-K; Document f6k_111821.htm.
- 2021-11-12: Form 6-K; Period of report 2021-09-30; Description FORM 6-K; Document f6k_111221.htm.